Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma

Dana Faratian, Alison Munro, Christopher Twelves, John M S Bartlett

Research output: Contribution to journalArticlepeer-review

Abstract

Membranous and cytoplasmic Ki67 immunoreactivity has recently been observed in a number of histopathological entities, but frequency of occurrence and relationship to prognosis in more common cancers have not been described. The aim was to describe the pattern and frequency of membranous/cytoplasmic Ki67 in a cohort of invasive breast carcinomas, and their associations with grade, HER2 amplification and oestrogen receptor (ER) expression.
Original languageEnglish
Pages (from-to)254-7
Number of pages4
JournalHistopathology
Volume54
Issue number2
DOIs
Publication statusPublished - Jan 2009

Fingerprint Dive into the research topics of 'Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma'. Together they form a unique fingerprint.

Cite this